Case report of a <em>KIT</em>-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy
Cong Luo(Central South University), Peng Liu(Shenyang Pharmaceutical University), Jiayu Shen(Zhejiang Chinese Medical University), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Xianhua Fang, Xiaohong Wang(Zhejiang Cancer Hospital), Zhixuan Fu
Cited by 8
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412